TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
成佳憲Chen, Chia-Hsien
- 計畫主持人
- 執行臨床試驗年資 12 年 9 個月
發表文獻
95筆
71
Cheng JC, Wu JK, Lee PC, Liu HS, Jian JJ, Lin YM, Sung JL, Jan GJ. Biological susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. International Journal of Radiation Oncology, Biology, Physics 60;1502-1509, 2004 (SCI)
72
Cheng JC*, Liu MC, Tsai SY, Fang WT, Jian JJ, Sung JL. Unexpectedly frequent hepatitis B reactivation by chemoradiation in post-gastrectomy patients. Cancer 101;2126-2133, 2004 (SCI)
73
Cheng JC*. The chance of further chemoembolization and intrahepatic disease control after radiotherapy to portal vein thrombus. International Journal of Radiation Oncology, Biology, Physics 58:1316, 2004 (Letter) (SCI)
74
Cheng JC*, Peng LC, Chen YH, Huang DY, Wu JK, Jian JJ. Unique role of proximal rectal dose in late rectal complication for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy. International Journal of Radiation Oncology, Biology, Physics 57:1010-1018, 2003 (SCI)
75
Cheng JC*, Wu JK, Huang CM, Liu HS, Huang DY, Tsai SY, Cheng SH, Jian JJ, Huang AT. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. International Journal of Radiation Oncology, Biology, Physics 56:229-234, 2003 (SCI)
76
Chen YH, Cheng JC*, Tsai SY, Cheng SH, Chang DS, Yang AL, Jian JJ. Definitive radiotherapy for the patients with prostatic adenocarcinoma: analysis of short-term outcome and prognostic factors. Therapeut Radiol Oncol 10:1-9, 2003
77
Cheng JC*. Recent advances in cancer therapy: Radiotherapy in cancer therapy. Formosan J Med 7:242-247, 2003
78
Cheng JC*, Wu JK, Huang CM, Liu HS, Huang DY, Cheng SH, Tsai SY, Jian JJ, Lin YM, Cheng TI, CF Horng, Huang AT. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: Dosimetric analysis and implication. International Journal of Radiation Oncology, Biology, Physics 54:156-162, 2002 (SCI)
79
Cheng JC*, Chen CM, Liu MC, Tsou MH, Yang PS, Jian JJ, Cheng SH, Tsai SY, Leu SY, Huang AT. Locoregional failure of post-mastectomy patients who had 1-3 positive axillary lymph nodes without adjuvant radiotherapy. International Journal of Radiation Oncology, Biology, Physics 52:980-988, 2002 (SCI)
80
Cheng JC*, Wu JK, Huang CM, Huang DY, Cheng SH, Lin YM, Jian JJ, Yang PS, Chuang VP, Huang AT. Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: Clinical manifestation and dosimetric description. Radiotherapy and Oncology, 63:41-45, 2002. (SCI)
